FDA reviews FHC stock (health company)

On Thursday the FDA panel reviews a company called whose stock is FHC. Company Reports Record Results for Fiscal Year 2008, at High End of Guidance. Net Income attributable to common stock holders rises 215% TO $4.8 MILLION ($0.18 per share).

Stock is currently trading at around $2.80.

PS: do not forget to enroll in the list of blog insiders. Enrollment is at no charge to you, and can be done by sending an email to marketwarnings (at) gmail (dot) com

Highlights:

Fourth Quarter -
- Net revenue up 52% to $7.8 million
- Net income attributable to common stockholders increases 108% to $2.3 million
- Gross profit margin widens to 44.8% of net revenues vs. 39.3% of net revenues in prior-year period
- Operating income exceeds $1 million for first quarter in Company's history
FY2008 -
- Unit sales up 34% to 34.7 million.
- Net revenue increases 33% to $25.6 million
- Operating income rises 252% to $3.2 million
- Net income attributable to common stockholders up 215% to $4.8 million

Gross profit increased 73% to $3.5 million, or 44.8% of net revenues, in the most recent quarter, compared with $2.0 million, or 39.3% of net revenues, in the fourth quarter of FY2007. Operating income increased 206% to $1.2 million in the three months ended September 30, 2008, compared with $0.4 million in the corresponding period of the previous fiscal year. This was the first quarter in which the Company reported operating income in excess of $1 million.

The Company expects significant quarter-to-quarter variations in its operating results, due to the timing of large order receipts, production scheduling, and shipping of products.

For the year ended September 30, 2008, net revenues increased 33% to $25.6 million, compared with $19.3 million in FY2007. Gross profit increased 50% to $10.7 million, Operating income rose to $3.2 million, a 252% improvement from $0.9 million in FY2007. In FY2008, the Company sold 34.7 million, an increase of 34% over the 25.9 million units sold in FY2007.

PS: do not forget to enroll in the list of blog insiders. Enrollment is at no charge to you, and can be done by sending an email to marketwarnings (at) gmail (dot) com

0 comments

Recent Entries

Recent Comments